The Traderszone Network

Published in TZ Latest News 19 April, 2016 by The TZ Newswire Staff

Is Heron Therapeutics’ Stock Now a Buy?

Sustol’s approval appears to be in the bag. Is Heron Therapeutics now a compelling buy?